Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07176962Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Role: lead

NCT07045571Recruiting

MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

Role: lead

NCT03546296Unknown

Dietary Factors and Risk of Gallbladder Carcinoma in China

Role: lead

All 3 trials loaded